PURITO ACNE INTENSIVE TREATMENT- salicylic acid patch

Purito Acne Intensive Treatment by

Drug Labeling and Warnings

Purito Acne Intensive Treatment by is a Otc medication manufactured, distributed, or labeled by Hinature Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredient

Salicylic Acid 2%

Purpose

Acne treatment

Uses

• for the treatment of acne
• helps clear up acne pimples

Warnings

For external use only.

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• clean the skin thoroughly before applying this product
• cover the entire affected area with one dot
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day
• Sensitivity Test for a New User. Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated above.

Other information

• Store in a cool, dry place.

Inactive ingredients

Arginine, Ascorbic Acid, Azelaic Acid, Butylene Glycol, Caprylyl Glycol, Cellulose Gum, Ethylhexylglycerin, Glycerin, Tea Tree (Melaleuca alternifolia) Extract, Niacinamide, Oligopeptide-76, Panthenol, Propanediol, Sodium Hyaluronate, Succinic Acid, 4-Terpineol, Tranexamic Acid, Trehalose, Zinc Hydrolyzed Hyaluronate, 1,2-Hexanediol.

Question or Comments?

research@purito.co.kr

Package Labeling

INGREDIENTS AND APPEARANCE

PURITO ACNE INTENSIVE TREATMENT 
salicylic acid patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 73251-011
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
ARGININE (UNII: 94ZLA3W45F)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
AZELAIC ACID (UNII: F2VW3D43YT)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
GLYCERIN (UNII: PDC6A3C0OX)
MELALEUCA ALTERNIFOLIA LEAF (UNII: G43C57162K)
NIACINAMIDE (UNII: 25X51I8RD4)
PANTHENOL (UNII: WV9CM0O67Z)
PROPANEDIOL (UNII: 5965N8W85T)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
SUCCINIC ACID (UNII: AB6MNQ6J6L)
4-TERPINEOL, (+/-)- (UNII: L65MV77ZG6)
TRANEXAMIC ACID (UNII: 6T84R30KC1)
TREHALOSE (UNII: B8WCK70T7I)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 73251-011-00	12 in 1 POUCH	03/09/2026
1		0.001 g in 1 CELLO PACK; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	03/09/2026

Labeler - Hinature Inc. (694862999)

Registrant - Hinature Inc. (694862999)